J 2021

Clinical Characteristics of Patients with Tick-Borne Encephalitis (TBE): A European Multicentre Study from 2010 to 2017

KOHLMAIER, B., N. SCHWEINTZGER, M. SAGMEISTER, Vendula SVENDOVA, D. KOHLFURST et. al.

Basic information

Original name

Clinical Characteristics of Patients with Tick-Borne Encephalitis (TBE): A European Multicentre Study from 2010 to 2017

Authors

KOHLMAIER, B., N. SCHWEINTZGER, M. SAGMEISTER, Vendula SVENDOVA (203 Czech Republic), D. KOHLFURST, A. SONNLEITNER, M. LEITNER, A. BERGHOLD, E. SCHMIEDBERGER, F. FAZEKAS, A. PICHLER, J. REJC-MARKO, Daniel RUZEK (203 Czech Republic), Lucie DUFKOVA (203 Czech Republic), Darina CEJKOVA (203 Czech Republic), Petr HUSA (203 Czech Republic, belonging to the institution), Martina PÝCHOVÁ (203 Czech Republic, belonging to the institution), Lenka KRBKOVÁ (203 Czech Republic, belonging to the institution), Vaclav CHMELIK (203 Czech Republic), Vera STRUNCOVA (203 Czech Republic), D. ZAVADSKA, G. KARELIS, A. MICKIENE, J. ZAJKOWSKA, P. BOGOVIC, F. STRLE and W. ZENZ (guarantor)

Edition

Microorganisms, Basel, MDPI, 2021, 2076-2607

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10606 Microbiology

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.926

RIV identification code

RIV/00216224:14110/21:00122108

Organization unit

Faculty of Medicine

UT WoS

000676591300001

Keywords in English

tick-borne encephalitis; vaccine-preventable disease; meningomyelitis; central paresis; peripheral paresis

Tags

International impact, Reviewed
Změněno: 18/8/2021 09:04, Mgr. Tereza Miškechová

Abstract

V originále

Tick-borne encephalitis (TBE) virus is a major cause of central nervous system infections in endemic countries. Here, we present clinical and laboratory characteristics of a large international cohort of patients with confirmed TBE using a uniform clinical protocol. Patients were recruited in eight centers from six European countries between 2010 and 2017. A detailed description of clinical signs and symptoms was recorded. The obtained information enabled a reliable classification in 553 of 555 patients: 207 (37.3%) had meningitis, 273 (49.2%) meningoencephalitis, 15 (2.7%) meningomyelitis, and 58 (10.5%) meningoencephalomyelitis; 41 (7.4%) patients had a peripheral paresis of extremities, 13 (2.3%) a central paresis of extremities, and 25 (4.5%) had single or multiple cranial nerve palsies. Five (0.9%) patients died during acute illness. Outcome at discharge was recorded in 298 patients. Of 176 (59.1%) patients with incomplete recovery, 80 (27%) displayed persisting symptoms or signs without recovery expectation. This study provides further evidence that TBE is a severe disease with a large proportion of patients with incomplete recovery. We suggest monitoring TBE in endemic European countries using a uniform protocol to record the full clinical spectrum of the disease.